SCHEMBL24637546

SCHEMBL24637546

CC(C)(C)C(=O)CCCCCNC(=O)CCN1C(=O)C=CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 7/20 0.44
▸ PTGS2 P35354 7/20 0.44
▸ MGLL Q99685 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ FAAH O00519 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ TLR9 Q9NR96 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ XBP1 P17861 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ GPR35 Q9HC97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24540974 0.87 PTGS1 (0.37) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL18995821 0.87 PTGS1 (0.51) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL19295812 0.86 PTGS1 (0.51) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL18161924 0.86 HDAC1 (0.39) PTGS1PTGS2SMN1; SMN2ALDH1A1MAPT
SCHEMBL10021410 0.85 PTGS1 (0.47) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL25113060 0.85 PTGS1 (0.47) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL10021407 0.85 PTGS1 (0.47) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL21388417 0.83 PTGS1 (0.46) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL20752853 0.83 PTGS1 (0.46) PTGS1PTGS2MGLLSMN1; SMN2FAAH
SCHEMBL12659454 0.83 NAMPT (0.47) PTGS1PTGS2MGLLSMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230097252-A1 LIGASE FUSION PROTEINS AND APPLICATION THEREOF GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2023-03-30 — — US disclosed
US-20220403360-A1 LIGASE FUSION PROTEINS AND APPLICATION THEREOF GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2022-12-22 — — US disclosed
US-11453870-B2 Ligase fusion proteins and application thereof GENEQUANTUM HEALTHCARE (SUZHOU) CO. LTD. (CN) 2022-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230097252-A1 LIGASE FUSION PROTEINS AND APPLICATION THEREOF LIG1, LIG3, STUB1 PTGS1 4352/4885PTGS2 4409/4885MGLL 1649/4885
US-20220403360-A1 LIGASE FUSION PROTEINS AND APPLICATION THEREOF LIG1, LIG3, STUB1 PTGS1 4352/4885PTGS2 4409/4885MGLL 1649/4885
US-11453870-B2 Ligase fusion proteins and application thereof LIG1, LIG3, STUB1 PTGS1 4352/4885PTGS2 4409/4885MGLL 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback